About the Authors
- Paweł Kawalec
-
* E-mail: pawel.kawalec@uj.edu.pl
Affiliations Drug Management Department, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University, Krakow, Poland, Centrum HTA Sp. z o.o. Sp. komandytowa, Krakow, Poland
- Joanna Kryst
-
Affiliation Centrum HTA Sp. z o.o. Sp. komandytowa, Krakow, Poland
- Alicja Mikrut
-
Affiliation Centrum HTA Sp. z o.o. Sp. komandytowa, Krakow, Poland
- Andrzej Pilc
-
Affiliations Drug Management Department, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University, Krakow, Poland, Department of Neurobiology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland
Competing Interests
We have no conflicts of interest to disclose in relation to this study. We would like to emphasize that three of the authors of the article are employed in Centrum HTA Sp z o.o. Sp komandytowa but that fact does not alter our adherence to all the PLoS One policies on sharing data and materials because the Centrum HTA was never involved in assessment of any of antiretroviral drugs; what is more Centrum HTA never co-operated with Boehringer Ingelheim which is trade owner of nevirapine (trade name Viramune). Authors of the article have no private or professional connection with neither Boehringer Ingelheim nor another pharmaceutical company involved in HIV drug investigation, development or manufacturing.
Author Contributions
Conceived and designed the experiments: PK JK. Performed the experiments: PK JK. Analyzed the data: PK JK AM. Contributed reagents/materials/analysis tools: PK. Wrote the manuscript: JK PK. Paper revising: PK AP.